PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 19, 1980New England Journal of Medicine703 citations

Epidemiology as a Guide to Clinical Decisions

View Full Paper
SHStephen B. HulleyRRRay H. RosenmanRBRichard Bawol

Key Points

  • The aim is to assess whether triglycerides causally contribute to coronary heart disease based on epidemiologic evidence.
  • Reviewed published studies on triglyceride and coronary heart disease associations

Structured PICO

Does widespread screening and treatment for hypertriglyceridemia prevent coronary heart disease in healthy persons?

P
Population
Healthy persons evaluated for the association between triglyceride levels and coronary heart disease
I
Intervention
Widespread screening and treatment for hypertriglyceridemia
O
Outcome
Coronary heart diseasehard clinical

The authors recommend abandoning widespread screening and treatment for hypertriglyceridemia in healthy persons due to a lack of persuasive evidence for a causal relationship with coronary heart disease.

Abstract

The hypothesis that triglyceride is a cause of coronary heart disease, although unconfirmed and never universally accepted, has nonetheless strongly influenced the practice of preventive medicine. We have examined the epidemiologic association between triglyceride and coronary heart disease to evaluate the validity of inferring that there is a causal relation between the two. Neither the evidence from published studies nor an analysis of data from the Western Collaborative Group Study provides strong support for the causal hypothesis. Information from other scientific disciplines is also meager, contrasting with the coherence of diverse evidence supporting the hypothesis that cholesterol is a cause of coronary heart disease. These arguments fall short of disproving the belief that lowering triglyceride will prevent coronary heart disease, especially since triglyceride and cholesterol are inextricably associated through mutual lipoprotein carriers. But we propose that the ethics of preventive medicine place the burden of proof on the proponents of intervention. We therefore recommend that widespread screening and treatment of healthy persons for hypertriglyceridemia be abandoned until more persuasive evidence becomes available.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hulley et al. (1980) studied this question.

synapsesocial.com/papers/6a1025f8d8c5cf602efdc0b7https://doi.org/10.1056/nejm198006193022503
Ask AI
Helpful
Bookmark
Share
View Full Paper